North America: Food, Drugs, Healthcare, Life Sciences

The California Legislature passed Assembly Bill (AB) 1415 on Sept. 8, 2025, which would require many management service organizations (MSOs) and other private equity and hedge...

Bergeson & Campbell, P.C. (B&C®) and Chemical Watch are pleased to present FIFRA Fundamentals, a two-day course taught by professionals from B&C's renowned Federal Insecticide, Fungicide...

The Make America Healthy Again (MAHA) Commission was established by President Donald Trump's Feb. 13, 2025, executive order (EO) 14212 titled "Establishing the President's Make America Healthy Again Commission."

In a landmark ruling the UPC Court of Appeal has for the first time in the pharmaceutical sector granted a provisional injunction for imminent patent infringement, clarifying that completing administrative procedures for generic drugs ...

Bergeson & Campbell, P.C. (B&C®) and Chemical Watch are pleased to present FIFRA Fundamentals, a two-day course taught by professionals from B&C's renowned Federal Insecticide, Fungicide...

The National Institutes of Health (NIH) recently announced the launch of a major artificial intelligence (AI) initiative aimed at improving the efficiency...

The California Legislature passed Assembly Bill (AB) 1415 on Sept. 8, 2025, which would require many management service organizations (MSOs) and other private equity and hedge...

In the Public Interest is excited to continue In That Case, its third annual miniseries examining notable decisions recently issued by the US Supreme Court.

The Make America Healthy Again (MAHA) Commission was established by President Donald Trump's Feb. 13, 2025, executive order (EO) 14212 titled "Establishing the President's Make America Healthy Again Commission."

On June 8, 2012, Genentech’s lawsuit seeking a declaration that US Patent No. 6,733,752 was invalid and not-infringed by Genentech’s trastuzumab product (HERCEPTIN).

Health Canada specifically contemplates certain proteins as SEBs in its Guidance, although Health Canada has not limited SEBs to only particular classes of drugs.

On May 23, 2012, the Federal Court held that Merck Frosst Canada Ltd. ("Merck") is liable to Apotex Inc. ("Apotex") for damages under section 8 of the Patented Medicines (Notice of Compliance) Regulations (the "Regulations"), but exercised its discretion to reduce the amount of compensation payable based on a defence of ex turpi causa.